Rheumatology News, Treatment Studies | Research & Management

Rheumatology

RHEUMATOLOGY

Feature Article

Cannabinoids in the Treatment of RA: Current Status and Future Prospects

Researchers found data that showed in patients with rheumatoid arthritis, the delta-tetrahydrocannabinol found in medical cannabis is likely to contribute to an increase in heart rate in patients who are susceptible to atherosclerosis and cardiovascular disease. Medical cannabis was also not found to provide therapeutic effects when comparing it with a combination of cannabinoid type 1 antagonist, fatty acid amide hydrolase inhibitor, and nonpsychotropic cannabidiol.

Latest

Next post in Rheumatology